Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
English
Deutsch
Home
Profiles
Research units
Projects
Research output
Equipment
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Targeting histone deacetylases in pancreatic ductal adenocarcinoma
Günter Schneider
, Oliver H. Krämer
, Petra Fritsche
, Susanne Schüler
, Roland M. Schmid
,
Dieter Saur
Institute of Exerimentelle Tumortherapie
Technical University of Munich
Friedrich Schiller University Jena
Research output
:
Contribution to journal
›
Article
›
peer-review
28
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeting histone deacetylases in pancreatic ductal adenocarcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
5-year Survival
20%
Advanced or Metastatic
20%
Angiogenesis
20%
Cancer Cells
20%
Clinical Relapse
20%
Clinical Setting
20%
Combination Therapy
20%
Effective Therapy
20%
Expression Pattern
20%
Histone Deacetylase Inhibitor (HDACi)
80%
Histone Deacetylases
100%
Isoenzymes
20%
Locally Advanced Cancer
20%
Median Survival
20%
Metastatic Tumor
20%
Mode of Action
20%
Molecular Mechanism
20%
Novel Therapeutic Targets
20%
Over 80
20%
Pancreatic Cancer
20%
Pancreatic Ductal Adenocarcinoma
100%
Proliferation Apoptosis
20%
Rational Therapeutics
20%
Therapeutic Strategies
20%
Medicine and Dentistry
Angiogenesis
16%
Cancer Cell
16%
Combination Therapy
16%
Diseases
16%
Histone Deacetylase
100%
Histone Deacetylase Inhibitor
50%
Isoenzyme
16%
Metastatic Carcinoma
16%
Pancreas Adenocarcinoma
100%
Pancreas Cancer
16%
Pancreatic Ductal Adenocarcinoma
16%
Programmed Cell Death
16%
Survival Rate
16%
Translating (Language)
16%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
16%
Diseases
16%
Histone Deacetylase
100%
Histone Deacetylase Inhibitor
50%
Isoenzyme
16%
Malignant Neoplasm
16%
Pancreas Adenocarcinoma
100%
Pancreas Cancer
16%
Survival Rate
16%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
20%
Cancer Cell
20%
Histone Deacetylase
100%
Histone Deacetylases Inhibitor
20%
Isoenzyme
20%
PDAC
20%
Programmed Cell Death
20%
Survival Rate
20%
Translating (Language)
20%